Indrayani Biotech Ltd's arm acquires India Home Health Care Pvt Ltd

IBL Healthcare Limited, a wholly owned subsidiary of Indrayani Biotech Limited has acquired 52,970 equity shares, constituting 51% of total no of equity shares, of M/S India Home Health Care Private Limited ("IHHCPL"). Thus, IHHCPL has become a subsidiary company of IBL Healthcare Limited.

India Home Health Care Private Limited ("IHHCPL") was established in 2009 for providing health care related services from the comfort of patient's home with a vision to touch million lives positively.

IHHCPL provides services such as, Orthopedic care, Cancer Care, Critical Care, Neuro care, Tracheostomy and Ventilator care, Palliative Care, Geriatric Care, PostSurgical Care and Wellness Services.

IHHCPL's advanced technology solution provides remote health care services which will be beneficial for the patients without travelling to hospital and incurring related expenses.

IHHCPL is fast becoming the reliable partner for leading Clinical Research Organizations (CRO) in the USA and Europe, conducting Clinical Trials, having already made significant inroads into this segment, under the brand name Avatar.

Avatar is targeting a revenue of around US$ 6 Million in the next 36 months from the current run rate of US$ 500 thousand.

IHHCPL is launching state of the art assisted living center in March 2023, with a vision to expand to 1000 units in the next 24 months.

IHHCPL is setting up a unique call center for assisting pharma companies in their patient support programs and operations are expected to commence in Q1 2023.

IHHCPL team, comprising eminent healthcare professionals from various streams, has acquired state of the art skills in collaboration with Bayada USA (largest home healthcare company with revenue of over US$ 3 billion) who happens to be an investor as well as knowledge partner for IHHCPL.

IHHCPL, to accomplish highest quality standards, has set up a training institute with advanced AI powered medical mannequin, for simulating all the critical conditions which can occur in a patient. All the medical staff of the company go through rigorous and comprehensive training before starting to serve the patients.

IHHCPL is targeting a revenue of INR 1 billion in the next 36 months.

Shares of INDRAYANI BIOTECH LTD. was last trading in BSE at Rs. 87.70 as compared to the previous close of Rs. 90.45. The total number of shares traded during the day was 85222 in over 331 trades.

The stock hit an intraday high of Rs. 92.50 and intraday low of 85.95. The net turnover during the day was Rs. 7504428.00.

Source : Equity Bulls

Keywords

INDRAYANIBIOTECH INE007C01021 IBLHealthcare Acquisition IndiaHomeHealthCare PatientCare PatientsHome